Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Steven James
Pharmacokinetics of Fentanyl Sublingual Spray in Opioid-Naïve Participants: Results of a Phase 1, Multiple Ascending Dose Study
Clinical Drug Investigation
Medicine
Pharmacology
Learning Portable Symbolic Representations
Related publications
Tanespimycin Monotherapy in Relapsed Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study
British Journal of Haematology
Hematology
Dose Proportionality and Pharmacokinetics Of carvedilol Sustained-Release Formulation: A single Dose-Ascending 10-Sequence Incomplete Block Study
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-In-Human Study of a Novel Antimalarial Drug
Malaria Research and Treatment
Epidemiology
Infectious Diseases
Multiple-Dose Pharmacokinetics of Amdinocillin in Healthy Volunteers
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Multiple-Dose Pharmacokinetics of Amdinocillin in Healthy Volunteers.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
KVD900 as a Single Dose, Rapid, Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema Attacks: Pharmacokinetic and Pharmacodynamic Results From a Phase 1 Single Ascending Dose Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
A Randomized, Placebo-Controlled, Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate Cyclase Stimulator Praliciguat in Healthy Subjects
Clinical Pharmacology in Drug Development
Pharmacology
Pharmaceutical Science
The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 Study
Clinical Cancer Research
Cancer Research
Oncology
Pharmacokinetics and Pharmacodynamics of a Human Monoclonal Anti-Fgf23 Antibody (KRN23) in the First Multiple Ascending-Dose Trial Treating Adults With X-Linked Hypophosphatemia
Journal of Clinical Pharmacology
Pharmacology
